Lymphocyte-predominant Hodgkin's disease: An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin study group

American Journal of Pathology

Volumn 150, Issue 3, 1997, Pages 793-803

  Von Wasielewski, Reinhard ^a   Werner, Martin ^a   Fischer, Robert ^b   Hansmann, Martin Leo ^c   Hübner, Klaus ^c   Hasenclever, Dirk ^d   Franklin, Jeremy ^b   Sextro, Michael ^b   Diehl, Volker ^b   Georgii, Axel ^a,e  

^a UNIVERSITY OF APPLIED SCIENCES AND ARTS   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURVIVAL; GERMANY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW;

ADULT; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD57; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031050881     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Pinkus GS, Said JW: Hodgkin's disease, lymphocyte predominance type, nodular: a distinct entity? Am J Pathol 1985, 11:1-6
2. Stein H, Hansmann ML, Lennert K, Brandtzaeg P, Gatter KO, Mason DY: Reed-Sternberg and Hodgkin cells in lymphocyte-predominance Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 1986, 86:292-297
3. Mason YD, Banks PM, Chan J, Cleary ML, Delsol G, de Wolf Peeters C. Falini B, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Müller-Hermelink K, Pileri S, Ralfkiaer E, Stein H, Warnke R: Nodular lymphocyte predominance Hodgkin's disease. Am J Surg Pathol 1994, 18:526-530
4. Stoler MH. Nichols GE, Symbuta M, Weiss LM: Lymphocyte predominance Hodgkin's disease: evidence for a κ light chain-restricted monotypic B-cell neoplasm. Am J Pathol 1995, 146:812-818
5. Kirn H, Zelman RJ, Fox MA, Bennett JM, Berard Cw, Butler JJ, Byrne GE, Dorfman RF, Harsock RJ, Lukes RJ, Mann RB, Neiman RS, Rebuck JW, Sheehan WW, Variakos D, Wilson JF, Rappaport H: Pathology panel for lymphoma clinical studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst 1982, 68:43-67
6. Bennet MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Vaughan Hudson G, Jelliffe AM: Analysis of histological subtypes in Hodgkin's disease in relation to prognosis and survival. The Cytobiology of Leukaemias and Lymphomas. Edited by D Auaglino, FGJ Hayhoe. New York, Raven Press, 1985, pp 15-32
7. Bennett MH. MacLennan KA, Vaughan Hudson G, Vaughan Hudson B: From the British National Lymphoma Investigation: non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI- A 20 year experience. Ann Oncol 1991, 2:83-92
8. Georgii A, Hübner K, Fischer R, Diehl V: Histologic typing of 3.000 Hodgkin's lymphomas: report from the German Hodgkin Trial. Abstracts Book of the Seventh Meeting of the EAHP (European Association for Haematopathology), Toledo/Spain, October 3-6, 1994
9. Hall PA, d'Ardenne AJ: Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol 1987, 40:1298-1304
10. Bishop PW, Harris M. Smith AP, Elsam KJ: Immunophenotypic study of lymphocyte predominance Hodgkin's disease. Histopathology 1991, 18:19-24
11. Poppema S: Lymphocyte-predominance Hodgkin's disease. Semin Diagn Pathol 1992, 9:257-264